CoChat

Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology

Vest, Katherine E., Phillips, Brittany L., Banerjee, Ayan, Apponi, Luciano H., Dammer, Eric B., Xu, Weiting, Zheng, Dinghai, Yu, Julia, Tian, Bin, Pavlath, Grace K., Corbett, Anita H. · 2017 · Human Molecular Genetics
Cited by 55

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddx206

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 72

  1. Victor, 1962, Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids, N. Engl. J. Med, 267, 1267, 10.1056/NEJM196212202672501 · doi:10.1056/nejm196212202672501
  2. Youssof, 2016, The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy, Muscle Nerve, 53, 694, 10.1002/mus.24932 · DOI
  3. Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat. Genet, 18, 164, 10.1038/ng0298-164 · DOI · Paper page
  4. Richard, 2015, PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling, J. Neuromuscul. Dis, 2, 175, 10.3233/JND-140060 · DOI · Paper page
  5. Jouan, 2014, An 18 alanine repeat in a severe form of oculopharyngeal muscular dystrophy, Can. J. Neurol. Sci, 41, 508, 10.1017/S0317167100018588 · DOI · Paper page
  6. Kerwitz, 2003, Stimulation of poly(A) polymerase through a direct interaction with the nuclear poly(A) binding protein allosterically regulated by RNA, embo. J, 22, 3705, 10.1093/emboj/cdg347 · DOI
  7. Kuhn, 2009, Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor, J. Biol. Chem, 284, 22803, 10.1074/jbc.M109.018226 · DOI · Paper page
  8. Wahle, 1995, Poly(A) tail length control is caused by termination of processive synthesis, J. Biol. Chem, 270, 2800, 10.1074/jbc.270.6.2800 · DOI · Paper page
  9. Jenal, 2012, The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites, Cell, 149, 538, 10.1016/j.cell.2012.03.022 · DOI · Paper page
  10. Li, 2015, Systematic profiling of poly(A)+ transcripts modulated by core 3' end processing and splicing factors reveals regulatory rules of alternative cleavage and polyadenylation, PLoS Genet, 11, e1005166., 10.1371/journal.pgen.1005166 · DOI · Paper page
  11. de Klerk, 2012, Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation, Nucleic Acids Res, 40, 9089, 10.1093/nar/gks655 · DOI · Paper page
  12. Tome, 1980, Nuclear inclusions in oculopharyngeal dystrophy, Acta Neuropathol, 49, 85, 10.1007/BF00692226 · DOI
  13. Fan, 2003, HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy, Can. J. Neurol. Sci, 30, 244, 10.1017/S0317167100002675 · DOI
  14. Corbeil-Girard, 2005, PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions, Neurobiol. Dis, 18, 551, 10.1016/j.nbd.2004.10.019 · DOI
  15. Tavanez, 2009, Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1, PLoS One, 4, e6418., 10.1371/journal.pone.0006418 · DOI
  16. Apponi, 2013, Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle, Skelet. Muscle, 3, 23., 10.1186/2044-5040-3-23 · DOI · Paper page
  17. Gidaro, 2013, Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients, J. Neuropathol. Exp. Neurol, 72, 234, 10.1097/NEN.0b013e3182854c07 · DOI
  18. Uyama, 2000, Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy, Muscle Nerve, 23, 1549, 10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0 · DOI
  19. Dion, 2005, Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice, Neurobiol. Dis, 18, 528, 10.1016/j.nbd.2004.09.021 · DOI
  20. Berciano, 2004, Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus, Hum. Mol. Genet, 13, 829, 10.1093/hmg/ddh101 · DOI
  21. Villagra, 2008, Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions, Mol. Cell. Neurosci, 37, 622, 10.1016/j.mcn.2007.12.012 · DOI
  22. Davies, 2010, Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy, Sci. Transl. Med, 2, 34ra40., 10.1126/scitranslmed.3000723 · DOI
  23. Davies, 2008, Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation, Hum. Mol. Genet, 17, 1097, 10.1093/hmg/ddm382 · DOI
  24. Davies, 2005, Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice, Nat. Med, 11, 672, 10.1038/nm1242 · DOI · Paper page
  25. Brais, 1995, The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13, Hum. Mol. Genet, 4, 429, 10.1093/hmg/4.3.429 · doi:10.1093/hmg/4.3.429
  26. Wang, 2006, Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis, Biochem. Biophys. Res. Commun, 340, 815, 10.1016/j.bbrc.2005.12.078 · doi:10.1016/j.bbrc.2005.12.078
  27. Raz, 2011, Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein, Am. J. Pathol, 179, 1988, 10.1016/j.ajpath.2011.06.044 · DOI · Paper page
  28. Catoire, 2008, Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1, Hum. Mol. Genet, 17, 2108, 10.1093/hmg/ddn109 · DOI · Paper page
  29. Chartier, 2006, A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1, embo J, 25, 2253, 10.1038/sj.emboj.7601117 · DOI · Paper page
  30. Hino, 2004, Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy, Hum. Mol. Genet, 13, 181, 10.1093/hmg/ddh017 · DOI
  31. Mankodi, 2012, Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy, Neurobiol. Dis, 45, 539, 10.1016/j.nbd.2011.09.010 · DOI
  32. Randolph, 2014, Ageing and muscular dystrophy differentially affect murine pharyngeal muscles in a region-dependent manner, J. Physiol, 592, 5301, 10.1113/jphysiol.2014.280420 · DOI · Paper page
  33. Anvar, 2013, A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging, Aging (Albany NY), 5, 412, 10.18632/aging.100567 · DOI
  34. Chartier, 2015, Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis, PLoS Genet, 11, e1005092., 10.1371/journal.pgen.1005092 · DOI
  35. Anvar, 2011, Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients, Skelet. Muscle, 1, 15., 10.1186/2044-5040-1-15 · DOI
  36. Trollet, 2010, Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres, Hum. Mol. Genet, 19, 2191, 10.1093/hmg/ddq098 · DOI
  37. Scheuermann, 2003, Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation, Protein Sci, 12, 2685, 10.1110/ps.03214703 · DOI
  38. Vest, 2015, An antibody to detect alanine-expanded pabpn1: a new tool to study oculopharyngeal muscular dystrophy, J. Neuromuscul. Dis, 2, 439, 10.3233/JND-150111 · DOI · Paper page
  39. Apponi, 2010, Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis, Hum. Mol. Genet, 19, 1058, 10.1093/hmg/ddp569 · DOI · Paper page
  40. Banerjee, 2013, PABPN1: molecular function and muscle disease, febs J, 280, 4230, 10.1111/febs.12294 · DOI · Paper page
  41. Cooper, 1999, In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle, J. Cell. Sci, 112, 2895, 10.1242/jcs.112.17.2895 · DOI · Paper page
  42. Chekanova, 2001, Analysis of an essential requirement for the poly(A) binding protein function using cross-species complementation, Curr. Biol, 11, 1207, 10.1016/S0960-9822(01)00371-2 · DOI
  43. Hoque, 2013, Analysis of alternative cleavage and polyadenylation by 3' region extraction and deep sequencing, Nat. Methods, 10, 133, 10.1038/nmeth.2288 · DOI · Paper page
  44. Huang da, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc, 4, 44, 10.1038/nprot.2008.211 · DOI · Paper page
  45. Huang da, 2009, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists, Nucleic Acids Res, 37, 1, 10.1093/nar/gkn923 · DOI · Paper page
  46. Cho, 2016, Perm1 enhances mitochondrial biogenesis, oxidative capacity, and fatigue resistance in adult skeletal muscle, faseb J, 30, 674, 10.1096/fj.15-276360 · DOI
  47. Riaz, 2016, PABPN1-Dependent mRNA Processing Induces Muscle Wasting, PLoS Genet, 12, e1006031., 10.1371/journal.pgen.1006031 · DOI
  48. Richard, 2017, Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy, Neurology, 88, 359, 10.1212/WNL.0000000000003554 · DOI
  49. Van Der Sluijs, 2003, Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint, J. Neurol, 250, 1307, 10.1007/s00415-003-0201-6 · doi:10.1007/s00415-003-0201-6
  50. Youssof, 2015, Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design, Neuromuscul. Disord, 25, 238, 10.1016/j.nmd.2014.11.010 · DOI
  51. Duddy, 2015, Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia, Skelet. Muscle, 5, 16., 10.1186/s13395-015-0041-y · DOI
  52. Tanabe, 1986, Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse, Acta Neuropathol, 69, 91, 10.1007/BF00687043 · DOI · Paper page
  53. Kelleher, 2015, REDD2 expression in rat skeletal muscle correlates with nutrient-induced activation of mTORC1: responses to aging, immobilization, and remobilization, Am. J. Physiol. Endocrinol. Metab, 308, E122, 10.1152/ajpendo.00341.2014 · DOI
  54. Miyazaki, 2009, REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch, Am. J. Physiol. Cell. Physiol, 296, C583, 10.1152/ajpcell.00464.2008 · DOI · Paper page
  55. Klein, 2016, Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing, Nucleic Acids Res, 44, 10929, 10.1093/nar/gkw703 · DOI · Paper page
  56. Gambelli, 2004, Mitochondrial abnormalities in genetically assessed oculopharyngeal muscular dystrophy, Eur. Neurol, 51, 144, 10.1159/000077070 · doi:10.1159/000077070
  57. Sadeh, 1993, Mitochondrial abnormalities in oculopharyngeal muscular dystrophy, Muscle Nerve, 16, 982
  58. Schroder, 1995, Oculopharyngeal muscular dystrophy: clinical and morphological follow-up study reveals mitochondrial alterations and unique nuclear inclusions in a severe autosomal recessive type, Neuropathol. Appl. Neurobiol, 21, 68, 10.1111/j.1365-2990.1995.tb01030.x · doi:10.1111/j.1365-2990.1995.tb01030.x
  59. Wong, 1996, Mitochondrial abnormalities in oculopharyngeal muscular dystrophy, Neuromuscul. Disord, 6, 163, 10.1016/0960-8966(95)00039-9 · DOI
  60. Malerba, 2017, PABPN1 gene therapy for oculopharyngeal muscular dystrophy, Nat. Commun, 8, 14848., 10.1038/ncomms14848 · DOI · Paper page
  61. Kepp, 2016, Alzheimer's disease due to loss of function: A new synthesis of the available data, Prog. Neurobiol, 143, 36, 10.1016/j.pneurobio.2016.06.004 · DOI · Paper page
  62. Arteaga-Bracho, 2016, Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease, Neurobiol. Dis, 96, 144, 10.1016/j.nbd.2016.09.006 · DOI · Paper page
  63. Messaed, 2007, Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy, Neurobiol. Dis, 26, 546, 10.1016/j.nbd.2007.02.004 · DOI
  64. Kontgen, 1993, Targeted disruption of the MHC class II Aa gene in C57BL/6 mice, Int. Immunol, 5, 957, 10.1093/intimm/5.8.957 · DOI · Paper page
  65. van der Weyden, 2005, Null and conditional semaphorin 3B alleles using a flexible puroDeltatk loxP/FRT vector, Genesis, 41, 171, 10.1002/gene.20111 · DOI · Paper page
  66. Ross, 2011, Visualization of mitochondrial respiratory function using cytochrome c oxidase/succinate dehydrogenase (COX/SDH) double-labeling histochemistry, J. Vis. Exp, 23, e3266
  67. Spinazzi, 2012, Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells, Nat. Protoc, 7, 1235, 10.1038/nprot.2012.058 · DOI · Paper page
  68. Zheng, 2016, 3'READS+, a sensitive and accurate method for 3' end sequencing of polyadenylated RNA, RNA., 22, 1631, 10.1261/rna.057075.116 · DOI
  69. Langmead, 2012, Fast gapped-read alignment with Bowtie 2, Nat Methods, 9, 357, 10.1038/nmeth.1923 · DOI · Paper page
  70. Dammer, 2015, Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins, Proteomics., 15, 508, 10.1002/pmic.201400189 · DOI · Paper page
  71. Smith, 1985, Measurement of protein using bicinchoninic acid, Anal. Biochem, 150, 76, 10.1016/0003-2697(85)90442-7 · DOI · Paper page
  72. Cox, 2011, Andromeda: a peptide search engine integrated into the MaxQuant environment, J. Proteome Res, 10, 1794, 10.1021/pr101065j · DOI · Paper page

Metadata

Authors
Vest, K. E., Phillips, B. L., Banerjee, A., Apponi, L. H., Dammer, E. B., Xu, W., Zheng, D., Yu, J., Tian, B., Pavlath, G. K., & Corbett, A. H.
Affiliations
  • Department of Pharmacology, Emory University School of Medicine, Atlanta, GA, USA
  • Department of Biology, Emory University, Atlanta, GA, USA
  • Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA
  • Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, USA
Venue
Human Molecular Genetics
Published
2017-05-29
Volume
26
Issue
17
Pages
3235-3252
ISSN
  • 0964-6906
  • 1460-2083
Cited by
55
References
5
Language
en
Funders
  • National Institutes of Health (5F32AR068207, 1F31AR069994, GM084089, NS069234, NS84870, and AR061987)
  • Muscular Dystrophy Association (255856, 157523, 276125, 422006)
  • Emory University School of Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.